We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+13.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.5B
AUM Growth
+$373M
(+3.4%)
Cap. Flow
-$871M
Cap. Flow
% of AUM
-7.58%
Top 10 Holdings %
Top 10 Hldgs %
26.56%
Holding
327
New
47
Increased
82
Reduced
128
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$60.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$60.2M |
| 3 |
Zimmer Biomet
ZBH
|
+$58.6M |
| 4 |
HCA Healthcare
HCA
|
+$51.7M |
| 5 |
US Foods
USFD
|
+$48.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$67.5M |
| 2 |
ServiceNow
NOW
|
+$64.3M |
| 3 |
Edwards Lifesciences
EW
|
+$57.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$48.5M |
| 5 |
IQVIA
IQV
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.26% |
| 2 | Financials | 22.36% |
| 3 | Healthcare | 17.74% |
| 4 | Communication Services | 10.2% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
176
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.6M | 0.1% |
104,505
-19,895
| -16% | -$2.05M |
|
177
Heritage Insurance Holdings
HRTG
$895M
| $11.3M | 0.1% |
850,000
-140,000
| -14% | -$1.92M |
|
178
Medtronic
MDT
$111B
| $11M | 0.1% |
96,598
+6,444
| +7% | +$707K |
|
179
Wheaton Precious Metals
WPM
$49.9B
| $10.7M | 0.09% |
+358,556
| New | +$9.8M |
|
|
MYOK
180
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.6M | 0.09% |
145,000
-205,000
| -59% | -$12.4M |
|
181
Wells Fargo
WFC
$263B
| $10.5M | 0.09% |
194,316
-685
| -0.4% | -$35.9K |
|
182
Blackstone
BX
$106B
| $10.3M | 0.09% |
184,151
-22,100
| -11% | -$1.15M |
|
183
Ares Capital
ARCC
$13.7B
| $10.2M | 0.09% |
549,050
-121,950
| -18% | -$2.26M |
|
184
BioMarin Pharmaceuticals
BMRN
$11.9B
| $10.1M | 0.09% |
120,000
-5,000
| -4% | -$378K |
|
|
FRC
185
DELISTED
First Republic Bank
FRC
| $10.1M | 0.09% |
86,090
-15,782
| -15% | -$1.7M |
|
186
US Bancorp
USB
$99.7B
| $9.97M | 0.09% |
168,089
+6,887
| +4% | +$398K |
|
187
Revvity
RVTY
$12.3B
| $9.39M | 0.08% |
96,669
-13,331
| -12% | -$1.19M |
|
188
Thermo Fisher Scientific
TMO
$212B
| $9.27M | 0.08% |
28,528
-5,692
| -17% | -$1.73M |
|
189
East-West Bancorp
EWBC
$18B
| $9.16M | 0.08% |
188,034
+53,191
| +39% | +$2.4M |
|
|
XENT
190
DELISTED
Intersect ENT, Inc
XENT
| $9.1M | 0.08% |
+365,339
| New | +$7.4M |
|
|
TPTX
191
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.03M | 0.08% |
+145,000
| New | +$6.9M |
|
|
AMRN
192
Amarin Corp
AMRN
$290M
| $8.58M | 0.07% |
20,000
-17,500
| -47% | -$6.65M |
|
193
Rockwell Automation
ROK
$52.3B
| $8.14M | 0.07% |
40,149
-2,534
| -6% | -$469K |
|
194
SLR Investment Corp
SLRC
$711M
| $7.72M | 0.07% |
374,550
-111,978
| -23% | -$2.3M |
|
|
YMAB
195
DELISTED
Y-mAbs Therapeutics
YMAB
| $7.66M | 0.07% |
245,000
+229,498
| +1,480% | +$6.79M |
|
196
Atlassian
TEAM
$25.9B
| $7.54M | 0.07% |
62,647
+22,020
| +54% | +$2.68M |
|
197
Enterprise Financial Services Corp
EFSC
$2.43B
| $7.46M | 0.06% |
154,748
+18,098
| +13% | +$803K |
|
|
SIVB
198
DELISTED
SVB Financial Group
SIVB
| $7.35M | 0.06% |
29,283
+1,667
| +6% | +$379K |
|
199
uniQure
QURE
$2.46B
| $7.17M | 0.06% |
+100,000
| New | +$5.49M |
|
200
Ascendis Pharma A/S
ASND
$16.3B
| $6.96M | 0.06% |
50,000
+25,000
| +100% | +$2.78M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Polar Capital held 327 positions worth $11.5B, up 3.4% from $11.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Polar Capital withdrew a net $871M in Q4 2019, closing 45 positions and reducing 128 holdings. Its most notable exit was Expedia Group, an estimated $67.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Polar Capital opened a new position in Stryker worth $61.3M.
- Polar Capital's largest Q4 2019 buy was Stryker: 291,829 shares worth $61.3M.
- Polar Capital added most to HCA Healthcare in Q4 2019, an estimated $51.7M increase.
- Polar Capital's biggest Q4 2019 reduction was ServiceNow, cutting an estimated $64.3M.
- Polar Capital fully exited Expedia Group in Q4 2019, selling an estimated $67.5M.
- Polar Capital's ten largest holdings make up 27% of its $11.5B portfolio in Q4 2019.
- Polar Capital opened 47 new positions and closed 45 in Q4 2019.
- Polar Capital's portfolio value rose 3.4% quarter-over-quarter to $11.5B.
Based on Polar Capital's 13F filing for Q4 2019, filed 14 Feb 2020.